会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
    • 抗胆碱能药,其制备方法和药物组合物
    • US06696462B2
    • 2004-02-24
    • US10345911
    • 2003-01-16
    • Christian EickmeierSabine GermeyerMatthias GrauertSabine PestelMichael P. PieperGeorg SpeckSteffen Breitfelder
    • Christian EickmeierSabine GermeyerMatthias GrauertSabine PestelMichael P. PieperGeorg SpeckSteffen Breitfelder
    • A61K31439
    • C07D451/06C07D451/10
    • A compound of formula 1 wherein: X- is an anion with a single negative charge; A and B, which are identical or different, are each —O—, —S—, —NH—, —CH2—, —CH═CH—, or —N(C1-C4-alkyl)—; R is hydrogen, hydroxy, —C1-C4-alkyl, —C1-C4-alkyloxy, —C1-C4-alkylene-halogen, —0—C1-C4-alkylene-halogen, —C1-C4-alkylene-OH, —CF3, —CHF2, —C1-C4-alkylene-C1-C4-alkyloxy, —0—COC1-C4-alkyl, —0—COC1-C4-alkylene-halogen, —C1-C4-alkylene-C3-C6-cycloalkyl, —0—COCF3, or halogen; R1 and R2, which are identical or different, are each —C1-C5-alkyl, which is optionally substituted by —C3-C6-cycloalkyl, hydroxy, or halogen, or R1 and R2 together are a —C3-C5-alkylene bridge; R3, R4, R3′, and R4′, which are identical or different, are each hydrogen, C1-C4-alkyl, C1-C4-alkyloxy, hydroxy, —CF3, —CHF2, —CN, —NO2, or halogen; RX and RX′, which are identical or different, are each hydrogen, C1-C4-alkyl, C1-C4-alkyloxy, hydroxy, —CF3, —CHF2, —CN, —NO2, or halogen, or RX and RX′ together are a single bond or a bridging group selected from —O—, —S—, —NH—, —CH2—, —CH2—CH2—, —N(C1-C4-alkyl)—, —CH(C1-C4-alkyl)—, and —C(C1-C4-alkyl)2—, or a pharmacologically acceptable acid addition salt thereof, processes for preparing, them and their use in pharmaceutical compositions.
    • 式1的化合物,其中X 1是具有单个负电荷的阴离子; A和B相同或不同,各自为-O - , - S - , - NH-, - CH 2 - , - CH = CH-或-N(C 1 -C 4 - 烷基) - ; R是氢,羟基,-C 1 -C 4 - 烷基,-C 1 -C 4 - 烷氧基,-C 1 -C 4 - 亚烷基 - 卤素,-O-C 1 -C 4 - 亚烷基 - 卤素,-C 1 -C 4 - 亚烷基-OH,-CF 3,-CHF 2,-C 1 -C 4 - 亚烷基-C 1 -C 4 - 烷氧基,-O-CCl-C 4 - 烷基,-O-CCl- - 卤素,-C 1 -C 4 - 亚烷基-C 3 -C 6 - 环烷基,-O-COCF 3或卤素; R 1和R 2各自为-C 1 -C 5 - 烷基, 任选被-C 3 -C 6 - 环烷基,羟基或卤素取代,或R 1和R 2一起是-C 3 -C 5亚烷基桥; R 3,R 4,R 3' R 1,R 2,R 3,R 4,R 4,R 4,R 4,R 4, X,R 1,R 2,R 2,R 2,R 2,R 3,R 3,R 3,R 3,R 3, X>和R X'一起是单键 或选自-O - , - S - , - NH - , - CH 2 - , - CH 2 -CH 2 - , - N(C 1 -C 4 - 烷基) - , - CH(C 1 -C 4烷基) 和-C(C 1 -C 4 - 烷基)2-或其药理学上可接受的酸加成盐,用于制备它们及其在药物组合物中的用途。